Individualized and precise management of childhood asthma based on BAT and memory Th2 cells

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035866

Enrollment

Unknown

Registered

2020-08-19

Start date

2020-09-30

Completion date

Unknown

Last updated

2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Wheezeing group:None

Step down therapy group:None

Withdraw therapy group:None

Eligibility

Sex/Gender

All

Age

No minimum to 14 Years

Inclusion criteria

Inclusion criteria: Children with history of wheezing episodes from 1 month to 6 years old or asthmatic children from 1 month to 14 years old

Exclusion criteria

Exclusion criteria: 1. foreign bodies in airway, congenital stenosis of airway, congenital heart disease and other chronic diseases; 2. infectious diseases; 3. Congenital immunodeficiency disease; 4. Other conditions that may not be suitable for this study.

Design outcomes

Primary

Measure	Time frame
basophil allergen threshold sensitivity (CD-sens);Memory Th2 cells;	—

Countries

China

Contacts

Public ContactWenwei Zhong

Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine

zhongwenwei@xinhuamed.com.cn+86 13816596929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026